Key facts
- This page summarizes Gregory J. Divis's Form 4 filing for Jaguar Health, Inc. (JAGX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 May 2022, 16:33.
Gregory J. Divis - 18 May 2022 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)
- Reporting relationship
- Director
- Issuer ticker
- JAGX
- Reported as of
- 18 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 May 2022, 16:33:45 UTC
- Prior SEC filing
- 30 Mar 2022
- Next SEC filing
- 31 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Greg J. Divis
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Gregory J. Divis filed Form 4 for Jaguar Health, Inc. (JAGX) on 18 May 2022.
Change
- Previous filing in this sequence was filed on 30 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JAGX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +12,133
- Change %
- Price
- Shares after
- 12,133
- Date
- 18 May 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
JAGX
transaction
Derivative
Restricted stock units
Options Exercise
- Transaction value
- $0
- Shares
- -12,133
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 12,133
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
On September 8, 2021, the issuer effected a 3-for-1 reverse stock split of the issued and outstanding shares of its voting common stock (the "Reverse Stock Split). Upon effectiveness of the Reverse Stock Split, every 3 shares of voting common stock was automatically converted into one share of voting common stock.
Footnote F3
The restricted stock units were previously reported as covering 36,400 shares, but were adjusted to reflect the Reverse Stock Split. Such restricted stock units were granted on May 18, 2021 and vested in full on May 18, 2022, the first anniversary of the grant date.